Cargando…
Topographical Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: Post Hoc Analysis of the CLARITY Randomized Clinical Trial
IMPORTANCE: Eyes with proliferative diabetic retinopathy have a variable response to treatment with panretinal photocoagulation (PRP) or anti–vascular endothelial growth factor agents. The location of neovascularization (NV) is associated with outcomes (eg, patients with disc NV [NVD] have poorer vi...
Autores principales: | Halim, Sandra, Nugawela, Manjula, Chakravarthy, Usha, Peto, Tunde, Madhusudhan, Savita, Lenfestey, Pauline, Hamill, Barbara, Zheng, Yalin, Parry, David, Nicholson, Luke, Greenwood, John, Sivaprasad, Sobha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953330/ https://www.ncbi.nlm.nih.gov/pubmed/33704351 http://dx.doi.org/10.1001/jamaophthalmol.2021.0108 |
Ejemplares similares
-
Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy
por: Nicholson, Luke, et al.
Publicado: (2018) -
Visual acuity outcome of stable proliferative diabetic retinopathy following initial complete panretinal photocoagulation
por: Fu, Dun Jack, et al.
Publicado: (2022) -
Infographic: intravitreous aflibercept vs vitrectomy with panretinal photocoagulation for vitreous haemorrhage from proliferative diabetic retinopathy
por: Song, Anna, et al.
Publicado: (2021) -
The Effectiveness of Conbercept Combined with Panretinal Photocoagulation vs. Panretinal Photocoagulation in the Treatment of Diabetic Retinopathy: A Meta-Analysis
por: Huang, Chao, et al.
Publicado: (2021) -
Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial
por: Abd Elhamid, Ahmed Hosni, et al.
Publicado: (2020)